Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
Body unavailable. Use the original source.
Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.